ASCO Expert Discusses the Use of Autologous Transplantation in Relapsed DLBCL

Nirav Niranjan Shah, MD, spoke about the use of autologous stem cell transplant in patients with relapsed, chemosensitive DLBCL during the era of CAR T-cell therapy.

Source: CancerNetwork - June 6, 2020 Category: Cancer & Oncology Authors: Nirav Niranjan Shah, MD Source Type: news